2011
CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in mice.
Weber C,
Meiler S,
Doring Y,
Koch M,
Drechsler M,
Megens RT,
Rowinska Z,
Bidzhekov K,
Fecher C,
Ribechini E,
van Zandvoort MA,
Binder CJ,
Jelinek I,
Hristov M,
Boon L,
Jung S,
Korn T,
Lutz MB,
Forster I,
Zenke M,
Hieronymus T,
Junt T,
Zernecke A.
J Clin Invest. 2011 Jul;121(7):2898-910.
2011
Homologous recombination of wild-type JAK2, a novel early step in the development of myeloproliferative neoplasm.
Vilaine M,
Olcaydu D,
Harutyunyan A,
Bergeman J,
Tiab M,
Ramee JF,
Chen JM,
Kralovics R,
Hermouet S.
Blood. 2011 Dec 8;118(24):6468-70.
2011
p19(ARF) /p14(ARF) controls oncogenic functions of signal transducer and activator of transcription 3 in hepatocellular carcinoma.
Schneller D,
Machat G,
Sousek A,
Proell V,
van Zijl F,
Zulehner G,
Huber H,
Mair M,
Muellner MK,
Nijman SM,
Eferl R,
Moriggl R,
Mikulits W.
Hepatology. 2011 Jul;54(1):164-72.
2011
Developmental control of imprinted expression by macro non-coding RNAs.
Santoro F,
Barlow DP.
Semin Cell Dev Biol. 2011 Jun;22(4):328-35.
2011
Identification of genomic aberrations associated with disease transformation by means of highresolution SNP array analysis in patients with myeloproliferative neoplasm.
Rumi E,
Harutyunyan A,
Elena C,
Pietra D,
Klampfl T,
Bagienski K,
Berg T,
Casetti I,
Pascutto C,
Passamonti F,
Kralovics R,
Cazzola M.
Am J Hematol. 2011 Dec;86(12): 974-9.
2011
IFIT1 is an antiviral protein that recognizes 5’-triphosphate RNA.
Pichlmair A,
Lassnig C,
Eberle CA,
Gorna MW,
Baumann CL,
Burkard TR,
Burckstummer T,
Stefanovic A,
Krieger S,
Bennett KL,
Rulicke T,
Weber F,
Colinge J,
Muller M,
Superti-Furga G.
Nat Immunol. 2011 Jul;12(7):624-30.
2011
The role of the JAK2 GGCC haplotype and the TET2 gene in familial myeloproliferative neoplasms.
Olcaydu D,
Rumi E,
Harutyunyan A,
Passamonti F,
Pietra D,
Pascutto C,
Berg T,
Jager R,
Hammond E,
Cazzola M,
Kralovics R.
Haematologica. 2011 Mar;96(3):367-74.
2011
Synthetic lethality: general principles, utility and detection using genetic screens in human cells.
Nijman SM.
FEBS Lett. 2011 Jan 3;585(1):1-6.
2011
A chemical-genetic screen reveals a mechanism of resistance to PI3K inhibitors in cancer.
Muellner MK,
Uras IZ,
Gapp BV,
Kerzendorfer C,
Smida M,
Lechtermann H,
Craig-Mueller N,
Colinge J,
Duernberger G,
Nijman SM.
Nat Chem Biol. 2011 Nov;7(11):787-93.
2011
Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity.
Miller YI,
Choi SH,
Wiesner P,
Fang L,
Harkewicz R,
Hartvigsen K,
Boullier A,
Gonen A,
Diehl CJ,
Que X,
Montano E,
Shaw PX,
Tsimikas S,
Binder CJ,
Witztum JL.
Circ Res. 2011 Jan 21;108(2):235-48.
